← Business Models: Core (all topics)
Contract manufacturing & outsourced production
What it is
One company manufactures a product that another owns, brands and sells. The brand owner keeps the formulation, design or customer relationship; the manufacturer supplies capacity, process capability and regulatory compliance
It runs under many names that obscure it being one model - loan-licence and CDMO in pharmaceuticals, custom synthesis and CRAMS in chemicals, EMS and ODM in electronics, private label in FMCG and tolling in metals
Impact on industries
- Lets the brand owner add capacity without capex and enter categories quickly, so growth is limited by demand rather than by plant
- For the manufacturer, qualification is the moat - an audited, filed and validated facility cannot be replicated quickly, so incumbency is durable
- The manufacturer owns no brand or customer, so it competes on cost and compliance and earns a conversion margin rather than the product's value
- Customer and molecule concentration is severe - a patent expiry or lost platform removes a revenue line with no substitute demand
Industries affected
Pharmaceuticals-Formulations-Large (Large-Cap)
Pharmaceuticals-Formulations-Medium (Mid-Cap)
CDMO & Contract Research
Speciality Chem-Fine Chemicals, Intermediates & CSM-Large (Large-Cap)
Speciality Chem-Fine Chemicals, Intermediates & CSM-Mid & Small
Industrial Electronics
FMCG-Home & Personal Care
Pesticides & Agrochemicals